A Randomized, Opel-Label Phase II/III Multicenter Study of High-Dose Immunosuppressive Therapy Using Total Body Irradiation, Cyclophosphamide, ATGAM, and Autologous Transplantation with AutoCD34+HPC Versus Intravenous Pulse Cyclophosphamide for the

Human Clinical Study - No abstract available

Estado	Finalizado
Fecha de inicio/Fecha fin	9/1/05 → 10/31/12

Detalles del proyecto